Topical Treatment of Psoriatic Dermatitis
Topical corticosteroids combined with vitamin D analogs are the first-line treatment for psoriatic dermatitis, with selection based on body location and disease severity. 1, 2
First-Line Treatment Options
Combination Therapy
- Topical corticosteroids + vitamin D analogs: Most effective first-line approach
Corticosteroid Selection by Body Region
Body/Extremities: Mid to high-potency corticosteroids
Face/Intertriginous/Genital Areas: Low-potency corticosteroids or calcineurin inhibitors
Scalp Psoriasis: Corticosteroid solutions, foams, or shampoos 5
Second-Line and Adjunctive Treatments
Tazarotene
- Can be used for mild to moderate psoriasis (Strength of recommendation: B) 1
- More effective when combined with mid/high-potency corticosteroids (Strength of recommendation: A) 1
- Combination decreases treatment duration and increases remission length 1
Emollients/Moisturizers
- Use in conjunction with topical corticosteroids for 4-8 weeks
- Helps reduce itching, desquamation, and total body surface area involvement
- Prevents quick relapse when corticosteroids are discontinued (Strength of recommendation: B) 1
Other Options
- Salicylic acid: Useful as keratolytic agent for thick plaques, enhances penetration of other topicals 5
- Anthralin: Effective but can cause staining; avoid on face and flexures 1
- Coal tar: Traditional treatment with anti-inflammatory properties 1
Application Technique and Dosing
- Fingertip Unit Method: One fingertip unit (medication from fingertip to first crease) covers approximately 2% body surface area 4
- Occlusive Dressings: May be used for recalcitrant psoriasis but should be discontinued if infection develops 3
- Calcipotriene (Vitamin D analog): Maximum 100g weekly to avoid hypercalcemia 2, 6
Treatment Monitoring and Considerations
- Evaluate response after 4 weeks for topical therapy 2
- Monitor for adverse effects:
- Corticosteroids: Skin atrophy, telangiectasia, striae
- Calcineurin inhibitors: Initial burning sensation
- Tazarotene: Skin irritation
Special Populations
Pediatric Patients
- Use lower potency corticosteroids
- Tacrolimus 0.1% recommended for facial and genital psoriasis in children 1
- Young children (0-6 years) are vulnerable to HPA suppression; use high-potency corticosteroids with caution 1
Treatment Algorithm
Mild localized disease:
- Start with topical corticosteroid + vitamin D analog combination
- Select potency based on location (low for face/intertriginous areas, medium-high for body)
For sensitive areas (face, genitals, intertriginous):
- First choice: Tacrolimus 0.1% ointment
- Alternative: Low-potency corticosteroids
For thick plaques:
- Add salicylic acid to enhance penetration
- Consider higher potency corticosteroids
For maintenance:
- Weekend corticosteroid use
- Weekday vitamin D analog use
- Regular emollient application
For inadequate response to topicals:
- Consider phototherapy or systemic agents for more extensive disease (>5% BSA) 2